Pairx

PairxPairx
Pairx

Pairx

Stealth modeStealth Mode

Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.

DR 02026Active
Rate

About

PairX Bio is a biotechnology startup focused on developing innovative cancer immunotherapies. Their platform leverages deep expertise in mRNA splicing biology and proprietary antigen validation methods to identify and target shared tumor-associated antigens derived from aberrantly spliced proteins. The company aims to create first- and best-in-class tumor-selective therapies for prevalent cancers.
Frequently asked

What does Pairx do?

PairX Bio is a biotechnology startup focused on developing innovative cancer immunotherapies. Their platform leverages deep expertise in mRNA splicing biology and proprietary antigen validation methods to identify and target shared tumor-associated antigens derived from aberrantly spliced proteins. The company aims to create first- and best-in-class tumor-selective therapies for prevalent cancers.

What is Pairx's Effective Domain Rating?

StartupHub's Effective Domain Rating for Pairx is 78 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 8, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.

Is Pairx trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Pairx is 86 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

When was Pairx founded?

Pairx was founded in 2026.

What industry does Pairx operate in?

Pairx operates in Drug Discovery, Biotechnology, Cancer Immunotherapy, Oncology, Therapeutics, Biopharma.

Comments

No comments yet. Be the first to share your take.